An ordinary differential equation model for the multistep transformation to cancer - PubMed (original) (raw)
An ordinary differential equation model for the multistep transformation to cancer
Sabrina L Spencer et al. J Theor Biol. 2004.
Abstract
Cancer is viewed as a multistep process whereby a normal cell is transformed into a cancer cell through the acquisition of mutations. We reduce the complexities of cancer progression to a simple set of underlying rules that govern the transformation of normal cells to malignant cells. In doing so, we derive an ordinary differential equation model that explores how the balance of angiogenesis, cell death rates, genetic instability, and replication rates give rise to different kinetics in the development of cancer. The key predictions of the model are that cancer develops fastest through a particular ordering of mutations and that mutations in genes that maintain genomic integrity would be the most deleterious type of mutations to inherit. In addition, we perform a sensitivity analysis on the parameters included in the model to determine the probable contribution of each. This paper presents a novel approach to viewing the genetic basis of cancer from a systems biology perspective and provides the groundwork for other models that can be directly tied to clinical and molecular data.
Similar articles
- Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
Karakosta A, Golias Ch, Charalabopoulos A, Peschos D, Batistatou A, Charalabopoulos K. Karakosta A, et al. J Exp Clin Cancer Res. 2005 Dec;24(4):505-14. J Exp Clin Cancer Res. 2005. PMID: 16471312 Review. - [Molecular basis of oncogenesis].
Paul S, Régulier E. Paul S, et al. Ann Biol Clin (Paris). 2001 Jul-Aug;59(4):393-402. Ann Biol Clin (Paris). 2001. PMID: 11470634 Review. French. - A stochastic model of cancer initiation including a bystander effect.
Østby I, Øyehaug L, Steen HB. Østby I, et al. J Theor Biol. 2006 Aug 21;241(4):751-64. doi: 10.1016/j.jtbi.2006.01.013. Epub 2006 Feb 24. J Theor Biol. 2006. PMID: 16499930 - Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development.
Fischer AH, Young KA, DeLellis RA. Fischer AH, et al. J Cell Biochem. 2004 Sep 1;93(1):28-36. doi: 10.1002/jcb.20105. J Cell Biochem. 2004. PMID: 15352159 Review. - Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M. Sigalotti L, et al. J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066. J Cell Physiol. 2007. PMID: 17458893 Review.
Cited by
- Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.
Ashdown ML, Robinson AP, Yatomi-Clarke SL, Ashdown ML, Allison A, Abbott D, Markovic SN, Coventry BJ. Ashdown ML, et al. F1000Res. 2015 Jul 13;4:232. doi: 10.12688/f1000research.6760.1. eCollection 2015. F1000Res. 2015. PMID: 26834979 Free PMC article. - A multilevel data integration resource for breast cancer study.
Mosca E, Alfieri R, Merelli I, Viti F, Calabria A, Milanesi L. Mosca E, et al. BMC Syst Biol. 2010 Jun 3;4:76. doi: 10.1186/1752-0509-4-76. BMC Syst Biol. 2010. PMID: 20525248 Free PMC article. - Modeling head and neck cancer stem cell-mediated tumorigenesis.
Pearson AT, Jackson TL, Nör JE. Pearson AT, et al. Cell Mol Life Sci. 2016 Sep;73(17):3279-89. doi: 10.1007/s00018-016-2226-x. Epub 2016 May 5. Cell Mol Life Sci. 2016. PMID: 27151511 Free PMC article. Review. - Quantitative interpretation of a genetic model of carcinogenesis using computer simulations.
Dai D, Beck B, Wang X, Howk C, Li Y. Dai D, et al. PLoS One. 2011 Mar 8;6(3):e16859. doi: 10.1371/journal.pone.0016859. PLoS One. 2011. PMID: 21408146 Free PMC article. - Data-Driven Methods for Advancing Precision Oncology.
Nedungadi P, Iyer A, Gutjahr G, Bhaskar J, Pillai AB. Nedungadi P, et al. Curr Pharmacol Rep. 2018 Apr;4(2):145-156. doi: 10.1007/s40495-018-0127-4. Epub 2018 Mar 6. Curr Pharmacol Rep. 2018. PMID: 33520605 Free PMC article.